Skip to main content

and
  1. Article

    Correction: C-reactive protein-to-albumin ratio as a risk factor for anastomotic leakage after anterior resection for rectal cancer with intraoperative use of indocyanine green fluorescence imaging

    Tatsunosuke Harada, Masakatsu Numata, Shota Izukawa, Yosuke Atsumi in Surgical Endoscopy (2024)

  2. No Access

    Article

    Influence of proficiency in conventional laparoscopic surgery in colorectal cancer on the introduction of robotic surgery

    Although there have been many reports on learning curves for robotic surgery, it is unclear how surgeons’ conventional laparoscopic surgical skills influence their ability in performing robotic surgery for col...

    Kenta Iguchi, Masakatsu Numata, Atsuhiko Sugiyama in Langenbeck's Archives of Surgery (2024)

  3. No Access

    Article

    C-reactive protein-to-albumin ratio as a risk factor for anastomotic leakage after anterior resection for rectal cancer with intraoperative use of indocyanine green fluorescence imaging

    Indocyanine green fluorescence imaging (ICG-FI) reduces anastomotic leakage (AL) in rectal cancer surgery. However, no studies investigating risk factors for anastomotic leakage specific to the group using ICG...

    Tatsunosuke Harada, Masakatsu Numata, Shota Izukawa, Yosuke Atsumi in Surgical Endoscopy (2024)

  4. No Access

    Article

    Analysis of surgical outcomes of laparoscopic versus open surgery for locally advanced mid-transverse colon cancer

    This study compared the surgical outcomes between laparoscopic colectomy (LC) and open colectomy (OC) for mid-transverse colon cancer (MTC).

    Kenta Iguchi, Masakatsu Numata, Manabu Shiozawa in Langenbeck's Archives of Surgery (2023)

  5. No Access

    Article

    Laparoscopic extended right hemicolectomy versus laparoscopic transverse colectomy for mid-transverse colon cancer: a multicenter retrospective study from Kanagawa Yokohama Colorectal Cancer (KYCC) study group

    The laparoscopic surgery approach for mid-transverse colon cancer (MTC) varies depending on tumor characteristics and the guidelines implemented by each surgeon; the optimal surgical procedure for MTC has not ...

    Kenta Iguchi, Masakatsu Numata in International Journal of Colorectal Disease (2022)

  6. No Access

    Article

    Comparison of safety and efficacy of fluorouracil + oxaliplatin + irinotecan (FOLFOXIRI) and modified FOLFOXIRI with bevacizumab for metastatic colorectal cancer: data from clinical practice

    The efficacy of fluorouracil + oxaliplatin + irinotecan with bevacizumab (FOLFOXIRI + BV) has been verified for metastatic colorectal cancer (mCRC). In clinical practice, the original (O-FOLFOXIRI + BV) and mo...

    Keisuke Kazama, Manabu Shiozawa in International Journal of Colorectal Disease (2022)

  7. No Access

    Article

    Study protocol: a multicenter randomized controlled trial of the multifaceted workload reduction of the anti-adhesion barrier for diverting ileostomy in laparoscopic rectal surgery, YCOG 2005 (ADOBARRIER study)

    There are few randomized controlled trials on the efficacy of spray-type anti-adhesion material during diverting ileostomy in laparoscopic rectal cancer surgery.

    Hiroki Ohya, Jun Watanabe, Kouki Goto in International Journal of Colorectal Disease (2021)

  8. No Access

    Article

    Prospective analysis of tumor spread to the small bowel mesentery in cases of right-sided colon cancer

    Guidelines advocate minimal ileal resection when right hemicolectomy is performed for right-sided colon cancer. The practice, thought to prevent malabsorption syndrome, does not appear to foster local recurren...

    Sumito Sato, Manabu Shiozawa, Nobuhiro Sugano in Langenbeck's Archives of Surgery (2020)

  9. No Access

    Article

    Surgical advantages of reduced-port laparoscopic gastrectomy in gastric cancer

    Although a few studies have reported the use of reduced-port laparoscopic gastrectomy (RPG) in gastric cancer patients, the feasibility of routinely using this technique remains unclear. It is therefore import...

    Chikara Kunisaki, Hirochika Makino, Naotaka Yamaguchi in Surgical Endoscopy (2016)

  10. No Access

    Article

    Lymphatic invasion identified with D2-40 immunostaining as a risk factor of nodal metastasis in T1 colorectal cancer

    The management of T1 colorectal cancer after local resection is controversial. Regional lymph node metastasis often occurs, requiring subsequent colonic resection. The aim of this study was to reevaluate the r...

    Hiroo Wada, Manabu Shiozawa, Nobuhiro Sugano in International Journal of Clinical Oncology (2013)

  11. No Access

    Article

    A phase II study of combination therapy with irinotecan and S-1 (IRIS) in patients with advanced colorectal cancer

    A combination of irinotecan with continuous infusional 5-fluorouracil (5-FU) is the standard treatment for advanced colorectal cancer. The aim of this study was to determine the efficacy and safety of combinin...

    Manabu Shiozawa, Makoto Akaike, Nobuhiro Sugano in Cancer Chemotherapy and Pharmacology (2010)

  12. Article

    Paraneoplastic neurological syndrome in a patient with gastric cancer

    Paraneoplastic neurological syndromes (PNSs) are a heterogeneous group of neurological disorders caused by immunemediated mechanisms. The incidence of PNS is much less than 1% for solid tumors, except for smal...

    Hitoshi Murakami, Yasushi Rino, Shoji Yamanaka, Yasuhisa Baba in Gastric Cancer (2010)

  13. Article

    Open Access

    Identification of colorectal cancer patients with tumors carrying the TP53mutation on the codon 72 proline allele that benefited most from 5-fluorouracil (5-FU) based postoperative chemotherapy

    Although postoperative chemotherapy is widely accepted as the standard modality for Dukes' stage C or earlier stage colorectal cancer (CRC) patients, biomarkers to predict those who may benefit from the therap...

    Ten-i Godai, Tetsuji Suda, Nobuhiro Sugano, Kazuhito Tsuchida in BMC Cancer (2009)

  14. No Access

    Article

    A phase I study of combination therapy with S-1 and irinotecan (CPT-11) in patients with advanced colorectal cancer

    The aim of this study was to determine the maximum tolerated dose, recommended dose and dose-limiting toxicities of irinotecan (CPT-11) plus S-1 in advanced colorectal cancer.

    Manabu Shiozawa, Nobuhiro Sugano in Journal of Cancer Research and Clinical On… (2009)

  15. No Access

    Article

    Long-term survival after multimodal therapy in a patient demonstrating intrahepatic cholangiocarcinoma with hilar invasion and intrahepatic metastases

    Cholangiocarcinoma is a therapeutically challenging malignancy. This report describes a case where the patient received multimodal therapy, including surgery, adjuvant chemoradiation therapy, and combination c...

    Soichiro Morinaga, Yuji Yamamoto in International Journal of Clinical Oncology (2008)